CD274 and neoplasm: However, studies have proved that the expression level of PD-L1 on tumor cell surface still has limitations as a criterion for patients to choose immunotherapy and to predict the prognosis of immunotherapy patients (Alexander, McMillan & Park, 2021; Martin & Märkl, 2019; Davis & Patel, 2019).